脊柱结核的诊断和治疗结果:一项整合GeneXpert MTB/RIF、组织病理学和临床管理策略的回顾性研究

IF 2.7 3区 医学 Q2 CLINICAL NEUROLOGY
European Spine Journal Pub Date : 2025-10-01 Epub Date: 2025-09-01 DOI:10.1007/s00586-025-09315-9
Prashant Adhikari, Isha Amatya, Pradeep Regmi, Jeevan Kumar Sharma, Raju Pangeni, Nishma Pokharel, Smriti Bhatta, Deepak Shrestha, Bhaskar Raj Pant, Sandeep Bhandari, Arun Dhakal, Eldin Karaikovic, Emre Acaroğlu
{"title":"脊柱结核的诊断和治疗结果:一项整合GeneXpert MTB/RIF、组织病理学和临床管理策略的回顾性研究","authors":"Prashant Adhikari, Isha Amatya, Pradeep Regmi, Jeevan Kumar Sharma, Raju Pangeni, Nishma Pokharel, Smriti Bhatta, Deepak Shrestha, Bhaskar Raj Pant, Sandeep Bhandari, Arun Dhakal, Eldin Karaikovic, Emre Acaroğlu","doi":"10.1007/s00586-025-09315-9","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>Spinal tuberculosis (STB) remains prevalent in developing nations and significantly contributes to morbidity, often resulting in kyphotic deformity and neurological deficits. In this study, we correlate the diagnostic, therapeutic and prognostic factors according to the current standard of management of STB.</p><p><strong>Methods: </strong>This retrospective study evaluated diagnostic and prognostic factors in 77 patients with STB treated surgically (37.7%) or non-surgically (62.3%) between 2018 and 2023. Diagnostic tools included GeneXpert MTB/RIF(GXMTB/RIF)- a rapid molecular test for detecting Mycobacterium tuberculosis and rifampicin resistance- and histopathological confirmation via biopsy. Clinical outcomes were assessed using Visual Analogue Scale, Oswestry Disability Index, inflammatory markers (ESR, CRP), kyphotic deformity correction, and neurological improvement.</p><p><strong>Results: </strong>GeneXpert MTB/RIF detected Mycobacterium tuberculosis in 94.8% of cases, with 5.2% showing rifampicin resistance. Histopathology revealed granulomatous infiltration in 96.1% of biopsies, underscoring the importance of combining diagnostic methods. Both groups showed significant improvement over 12 months, with surgical patients exhibiting higher baseline kyphosis angles (47.41° vs. 19.27°, p < 0.001) and greater post-treatment correction (14.14° vs. 2.71°, p = 0.04). Neurological status, evaluated via ASIA Impairment Scale improved post-treatment, with 93.5% achieving normal neurology. Deformity presence strongly correlated with surgical intervention (51.9% vs. 8%, p < 0.001).</p><p><strong>Conclusion: </strong>The study highlights the efficacy of anti-tubercular therapy (ATT) and the role of surgery in severe deformity or neurological compromise. Notably, rare discrepancies between GXMTB/RIF and histopathology (5.2% GXMTB/RIF - negative but histopathology- positive) emphasize the need for clinical judgment alongside laboratory findings. Surgical intervention is pivotal for deformity correction and neurological recovery, while ATT remains the cornerstone.</p>","PeriodicalId":12323,"journal":{"name":"European Spine Journal","volume":" ","pages":"4740-4748"},"PeriodicalIF":2.7000,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Diagnostic and therapeutic outcomes in spinal tuberculosis: a retrospective study integrating GeneXpert MTB/RIF, histopathology, and clinical management strategies.\",\"authors\":\"Prashant Adhikari, Isha Amatya, Pradeep Regmi, Jeevan Kumar Sharma, Raju Pangeni, Nishma Pokharel, Smriti Bhatta, Deepak Shrestha, Bhaskar Raj Pant, Sandeep Bhandari, Arun Dhakal, Eldin Karaikovic, Emre Acaroğlu\",\"doi\":\"10.1007/s00586-025-09315-9\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Purpose: </strong>Spinal tuberculosis (STB) remains prevalent in developing nations and significantly contributes to morbidity, often resulting in kyphotic deformity and neurological deficits. In this study, we correlate the diagnostic, therapeutic and prognostic factors according to the current standard of management of STB.</p><p><strong>Methods: </strong>This retrospective study evaluated diagnostic and prognostic factors in 77 patients with STB treated surgically (37.7%) or non-surgically (62.3%) between 2018 and 2023. Diagnostic tools included GeneXpert MTB/RIF(GXMTB/RIF)- a rapid molecular test for detecting Mycobacterium tuberculosis and rifampicin resistance- and histopathological confirmation via biopsy. Clinical outcomes were assessed using Visual Analogue Scale, Oswestry Disability Index, inflammatory markers (ESR, CRP), kyphotic deformity correction, and neurological improvement.</p><p><strong>Results: </strong>GeneXpert MTB/RIF detected Mycobacterium tuberculosis in 94.8% of cases, with 5.2% showing rifampicin resistance. Histopathology revealed granulomatous infiltration in 96.1% of biopsies, underscoring the importance of combining diagnostic methods. Both groups showed significant improvement over 12 months, with surgical patients exhibiting higher baseline kyphosis angles (47.41° vs. 19.27°, p < 0.001) and greater post-treatment correction (14.14° vs. 2.71°, p = 0.04). Neurological status, evaluated via ASIA Impairment Scale improved post-treatment, with 93.5% achieving normal neurology. Deformity presence strongly correlated with surgical intervention (51.9% vs. 8%, p < 0.001).</p><p><strong>Conclusion: </strong>The study highlights the efficacy of anti-tubercular therapy (ATT) and the role of surgery in severe deformity or neurological compromise. Notably, rare discrepancies between GXMTB/RIF and histopathology (5.2% GXMTB/RIF - negative but histopathology- positive) emphasize the need for clinical judgment alongside laboratory findings. Surgical intervention is pivotal for deformity correction and neurological recovery, while ATT remains the cornerstone.</p>\",\"PeriodicalId\":12323,\"journal\":{\"name\":\"European Spine Journal\",\"volume\":\" \",\"pages\":\"4740-4748\"},\"PeriodicalIF\":2.7000,\"publicationDate\":\"2025-10-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"European Spine Journal\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1007/s00586-025-09315-9\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/9/1 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q2\",\"JCRName\":\"CLINICAL NEUROLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Spine Journal","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s00586-025-09315-9","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/9/1 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0

摘要

目的:脊柱结核(STB)在发展中国家仍然普遍存在,并显著导致发病率,通常导致脊柱后凸畸形和神经功能缺损。在本研究中,我们根据目前的STB管理标准,将诊断、治疗和预后因素联系起来。方法:本回顾性研究评估了2018年至2023年间77例STB手术(37.7%)或非手术(62.3%)患者的诊断和预后因素。诊断工具包括GeneXpert MTB/RIF(GXMTB/RIF)——一种用于检测结核分枝杆菌和利福平耐药性的快速分子检测方法——以及通过活检进行的组织病理学证实。临床结果通过视觉模拟量表、Oswestry残疾指数、炎症标志物(ESR、CRP)、后凸畸形矫正和神经系统改善进行评估。结果:GeneXpert MTB/RIF检出结核分枝杆菌94.8%,其中5.2%显示利福平耐药。组织病理学显示肉芽肿浸润在96.1%的活检,强调综合诊断方法的重要性。两组在12个月内均有显著改善,手术患者的基线后凸角度更高(47.41°vs. 19.27°)。结论:该研究强调了抗结核治疗(ATT)的疗效以及手术在严重畸形或神经损伤中的作用。值得注意的是,GXMTB/RIF与组织病理学之间罕见的差异(5.2%的GXMTB/RIF阴性,但组织病理学阳性)强调了临床判断和实验室结果的必要性。手术干预是畸形矫正和神经恢复的关键,而ATT仍然是基石。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Diagnostic and therapeutic outcomes in spinal tuberculosis: a retrospective study integrating GeneXpert MTB/RIF, histopathology, and clinical management strategies.

Purpose: Spinal tuberculosis (STB) remains prevalent in developing nations and significantly contributes to morbidity, often resulting in kyphotic deformity and neurological deficits. In this study, we correlate the diagnostic, therapeutic and prognostic factors according to the current standard of management of STB.

Methods: This retrospective study evaluated diagnostic and prognostic factors in 77 patients with STB treated surgically (37.7%) or non-surgically (62.3%) between 2018 and 2023. Diagnostic tools included GeneXpert MTB/RIF(GXMTB/RIF)- a rapid molecular test for detecting Mycobacterium tuberculosis and rifampicin resistance- and histopathological confirmation via biopsy. Clinical outcomes were assessed using Visual Analogue Scale, Oswestry Disability Index, inflammatory markers (ESR, CRP), kyphotic deformity correction, and neurological improvement.

Results: GeneXpert MTB/RIF detected Mycobacterium tuberculosis in 94.8% of cases, with 5.2% showing rifampicin resistance. Histopathology revealed granulomatous infiltration in 96.1% of biopsies, underscoring the importance of combining diagnostic methods. Both groups showed significant improvement over 12 months, with surgical patients exhibiting higher baseline kyphosis angles (47.41° vs. 19.27°, p < 0.001) and greater post-treatment correction (14.14° vs. 2.71°, p = 0.04). Neurological status, evaluated via ASIA Impairment Scale improved post-treatment, with 93.5% achieving normal neurology. Deformity presence strongly correlated with surgical intervention (51.9% vs. 8%, p < 0.001).

Conclusion: The study highlights the efficacy of anti-tubercular therapy (ATT) and the role of surgery in severe deformity or neurological compromise. Notably, rare discrepancies between GXMTB/RIF and histopathology (5.2% GXMTB/RIF - negative but histopathology- positive) emphasize the need for clinical judgment alongside laboratory findings. Surgical intervention is pivotal for deformity correction and neurological recovery, while ATT remains the cornerstone.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
European Spine Journal
European Spine Journal 医学-临床神经学
CiteScore
4.80
自引率
10.70%
发文量
373
审稿时长
2-4 weeks
期刊介绍: "European Spine Journal" is a publication founded in response to the increasing trend toward specialization in spinal surgery and spinal pathology in general. The Journal is devoted to all spine related disciplines, including functional and surgical anatomy of the spine, biomechanics and pathophysiology, diagnostic procedures, and neurology, surgery and outcomes. The aim of "European Spine Journal" is to support the further development of highly innovative spine treatments including but not restricted to surgery and to provide an integrated and balanced view of diagnostic, research and treatment procedures as well as outcomes that will enhance effective collaboration among specialists worldwide. The “European Spine Journal” also participates in education by means of videos, interactive meetings and the endorsement of educative efforts. Official publication of EUROSPINE, The Spine Society of Europe
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信